Quantitative measurements of steroid receptors and their messenger ribonucleic acids with a special emphasis on polymerase chain reaction

Journal of Laboratory and Clinical Medicine

Volumn 137, Issue 6, 2001, Pages 383-397

  Stavréus Evers, Anneli ^a   Cekan, Sten Z ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MEASUREMENT; MESSENGER RNA; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; STEROID RECEPTOR;

EID: 0035370323     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2001.115098     Document Type: Article

References (120)

1. Cekan SZ. Quantitative analysis of steroid hormone receptors and their messenger ribonucleic acids. J Lab Clin Med 1994;124:606-22.
2. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-Å. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci 1996; 93:5925-30.
3. Mosselman S, Polman J, Dijkema R. ERβ: Identification and characterization of a novel human estrogen receptor. FEBS Lett 1996;392:49-53.
4. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, et al. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol Endocrinol 1997;11:353-65.
5. Leygue E, Dotzlaw H, Lu B, Glor C, Watson PH, Murphy LC. Estrogen receptor β: Mine is longer than yours? J Clin Endocrinol Metab 1998;83:3754-5.
6. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997;138:863-70.
7. Gustafsson J-A. Therapeutic potential of selective estrogen modulators. Curr Opin Chem Biol 1998;2:508-11.
8. Shupnik MA, Pitt LK, Soh AY, Anderson A, Lopes B, Laws ER. Selective expression of estrogen receptor α and β isoforms in human pituitary tumors. J Clin Endocrinol Metab 1998;83:3965-72.
9. Inoue S, Hoshino S, Miyoshi H, Akishita M, Hosoi T, Orimo H, et al. Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells. Biochem Biophys Res Commun 1996; 219:766-72.
10. Rey JM, Pujol P, Dechaud H, Edouard E, Hedon B, Maudelonde T. Expression of oestrogen receptor-α splicing variants and oestrogen receptor-β in endometrium of infertile patients. Mol Hum Reprod 1998;4:641-7.
11. Mito K, Tamura T, Hosokawa K, Kondo T, Yamamoto T, Honjo H. Expression of exon 5 deleted estrogen receptor variant messenger RNA in human uterine endometrium and leiomyoma. J Steroid Biochem Mol Biol 1998;67:9-16.
12. Hori M, Iwasaki M, Yoshimi F, Asato Y, Itabashi M. Determination of estrogen receptor in primary breast cancer using two different monoclonal antibodies, and correlation with its mRNA expression. Pathol Int 1999;49:191-7.
13. Kuiper G, Warner M, Gustafsson J-A. Estrogen receptor β in the pharmacology of estrogens and antiestrogens. In: Oettel M, Schillinger E, editors. Estrogens and Antiestrogens II. Berlin: Springer; 1999. p. 95-104.
14. Flouriot G, Griffin C, Kenealy M, Sonntag-Buck V, Gannon F. Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha-gene are generated by alternative splicing and promoter usage. Mol Endocrinol 1998;12: 1939-54.
15. Romain S, Spyratos F, Goussard J, Formento J-L, Magdelenat H. Improvement of quality control for steroid receptor measurements: Analysis of distributions in more than 40000 primary breast cancers. Breast Cancer Res Treat 1996;41: 131-9.
16. Al Saati T, Clamens S, Cohen-Knafo E, Faye JC, Prats H, Coindre JM, et al. Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer 1993;55:651-4.
17. Kohen F, Abel L, Sharp A, Amir-Zaltsman Y, Sömjen D, Luria S, et al. Estrogen receptor expression and function in thymocytes in relation to gender and age. Dev Immunol 1998;5:277-85.
18. Telleria CM, Zhong L, Deb S, Srivastava RK, Park KS, Sugino N, et al. Differential expression of the estrogen receptors α and β in the rat corpus luteum of pregnancy: Regulation by prolactin and placental lactogens. Endocrinology 1998:139:2432-42.
19. Pasanen S, Ylikomi T, Palojoki E, Syvälä H, Pelto-Huikko M, Tuohimaa P. Progesterone receptor in chicken bursa of fabricius and thymus: Evidence for expression in b-lymphocytes. Mol Cell Endocrinol 1998;141:119-28.
20. Sternberger LA, Hardy PH, Cuculis JJ, Meyer HG. The unlabeled antibody enzyme method of immunochemistry. J Histochem Cytochem 1970;18:315-33.
21. Castagnetta LA, Miceli MD, Sorci CMG, Pfeffer U, Farruggio R, Oliveri G, et al. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology 1995;136:2309-19.
22. Groyer-Picard MT, Vu-Hai MT, Milgrom E, Perrot-Applanat M. Monoclonal antibodies for immunocytochemistry of progesterone receptors (PR) in various laboratory rodents, livestock, humans, and chickens: Identification of two epitopes conserved in PR of all these species. Endocrinology 1990;126:1485-91.
23. Zaino RJ, Feil PD, Clarke CL, Mortel R, Satyaswaroop PG. A polyclonal antiserum against the rabbit progesterone receptor recognizes the human receptor: Immunohistochemical localization in rabbit and human uterus. Cell Biochem Funct 1989;7:147-52.
24. Lessl M, Klotzbuecher M, Schoen S, Reles A, Stöckeman K, Fuhrman U. Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium. J Clin Endocrinol Metab 1997;82:2596-600.
25. Roger P, Pujol P, Lucas A, Baldet P, Rochefort H. Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human epithelial tumors. Am J Pathol 1998; 153:1579-88.
26. Wang H, Masironi B, Eriksson H, Sahlin L. A comparative study of estrogen receptors α and β in the rat uterus. Biol Reprod 1999;61:955-64.
27. Touraine P, Martini J-F, Zafrani B, Durand J-C, Labaille F, Malet C, et al. Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumours versus normal breast tissues. J Clin Endocrinol Metab 1998;83:667-74.
28. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994;89:1943-50.
29. Dunlap KD, Zakon HH. Behavioral actions of androgens and androgen receptor expression in the electrocommunication system of an electric fish, Eigenmannia virescens. Horm Behav 1998;34:30-8.
30. Catasus L, Machin P, Matias-Guiu X, Prat J. Microsatellite instability in endometrial carcinomas: Clinicopathologic correlations in a series of 42 cases. Hum Pathol 1998;29:1160-4.
31. Perrot-Applanat M, Groyer-Picard MT, Vu-Hai MT, Pallud C, Spyratos F, Milgrom E. Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancer. Am J Pathol 1989;135:457-68.
32. Goulding H, Pinder S, Cannon P, Pearson D, Nicholson R, Snead D, et al. A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol 1995;26:291-4.
33. Shi S-R, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:-741-8.
34. Lou H, Martin MB, Stoikca A, Ramwell PW, Foegh ML. Upregulation of estrogen receptor-α expression in rabbit cardiac allograft. Circ Res 1998;83:947-51.
35. Leal C, Costa I, Fonseca D, Lopes P, Bento M-J, Lopes C. Intracystic (encysted) papillary carcinoma of the breast: A clinical, pathological, and immunohistochemical study. Hum Pathol 1998;29:1097-104.
36. Mander BJ, Heal K, Porushotham AD, Wishart GC. Oestrogen-receptor status in management of breast cancer in UK. Lancet 1998;352:36-7.
37. Möller C, Arner P, Sonnenfeld T, Norstedt G. Quantitative comparison of insulin-like growth factor mRNA levels in human and rat tissues analysed by a solution hybridization assay. J Mol Endocrinol 1991;7:213-22.
38. Sahlin L, Holmgren A, Eriksson H. Thioredoxin messenger ribonucleic acid is regulated by estradiol in the rat uterus. Biol Reprod 1997;57:1056-9.
39. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 2000;85:2897-902.
40. Kawasaki ES. Amplification of RNA. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR Protocols. San Diego: Academic Press; 1990. p. 21-7.
41. Eidne KA. The polymerase chain reaction and its uses in endocrinology. Trends Endocrinol Metab 1991;2:169-75.
42. Kanatani M, Sugimoto T, Takahashi Y, Kaji H, Kitazawa R, Chihara K. Estrogen via the estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast formation. J Bone Miner Res 1998;13:854-62.
43. Morrissey JP, Raney S. A metastatic breast tumor cell line, GI-101A, is estrogenic receptor positive and responsive to estrogen but resistant to tamoxifen. Cell Biol Int 1998;22: 413-9.
44. PCR Application Manual. 2nd Ed. Steffen C, editor. Mannheim, Germany: Roche Diagnostics; 1999.
45. Wang AM, Doyle MW, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci 1989; 86:9717-21.
46. Singer-Sam J, Robinson MO, Bellvé AR, Simon MI, Riggs AD. Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, Mtase, and Zfy gene transcripts during mouse spermatogenesis. Nucleic Acids Res 1990;18: 1255-9.
47. Myers TW, Gelfand DH. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry 1991;30:7661-6.
48. Gilliland G, Perrin S, Bunn HF. Competitive PCR for quantitation of mRNA. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR Protocols. San Diego: Academic Press; 1990. p. 60-9.
49. Gomella LG, Raj GV, Moreno JG. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J Urol 1997;158:326-37.
50. Jones P, Qiu J, Rickwood D, editors. RNA Isolation and Analysis. Oxford: Bios; 1994. p. 129-43.
51. Wang AM, Mark DF. Quantitative PCR. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR Protocols. San Diego: Academic Press; 1990. p. 70-5.
52. Innis MA, Gelfand DH. Optimization of PCRs. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR Protocols. San Diego: Academic Press; 1990. p. 3-12.
53. Higuchi R, Krummel B, Saiki RK. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions. Nucleic Acids Res 1988;16:7351-67.
54. Mousatsatsou P, Kassi E, Creatsas G, Coulocheri S, Scheller K, Sekeris CE. Detection of oestrogen receptor variants in endometrium, myometrium, leiomyoma and peripheral blood mononuclear cells: Comparison to variants present in breast cancer. J Cancer Res Clin Oncol 1998;124:478-84.
55. Rutherford T, Brown WD, Sapi E, Aschkenazi S, Munoz A, Mor G. Absence of estrogen receptor-β expression in metastatic ovarian cancer. Obstet Gynecol 2000;96:417-21.
56. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD, editors. Molecular Biology of the Cell, Second Edition. New York: Garland; 1989. p. 260-9.
57. Marx JL. Multiplying genes by leaps and bounds. Science 1988;240:1408-9.
58. Wiesner RJ, Rüegg JC, Morano I. Counting target molecules by exponential polymerase chain reaction: Copy number of mitochondrial DNA in rat tissues. Biochem Biophys Res Commun 1992;183:553-9.
59. Rosenfeld CS, Ganjam VK, Taylor JA, Yuan X, Stiehr LR, Hardy MP, et al. Transcription and translation of estrogen receptor-beta in the male reproductive tract of estrogen receptor-alpha knock-out and wild-type mice. Endocrinology 1998;139:2982-7.
60. Rosenfeld CS, Yuan X, Manikkam M, Calder MD, Garverick HA, Lubahn DB. Cloning, sequencing and localization of bovine estrogen receptor-beta within the ovarian follicle. Biol Reprod 1999;60:691-7.
61. Knowlden JM, Gee JMW, Robertson JFR, Ellis IO, Nicholson RI. A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer. Int J Cancer 2000;89:209-12.
62. Lau K-M, Leav I, Ho S-M. Rat estrogen receptor α and β, and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the noble rats. Endocrinology 1998;139:424-7.
63. Fuqua SAW, Falette NF, McGuire WL. Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay. J Natl Cancer Inst 1990;82:858-61.
64. Salomon RN, Underwood R, Doyle MV, Wang A, Libby P. Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc Natl Acad Sci 1992;89:2814-8.
65. Landgraf A, Reckman B, Pingoud A. Quantitative analysis of polymerase chain reaction (PCR) products using primers labeled with biotin and a fluorescent dye. Anal Biochem 1991;193:231-5.
66. Levenson C, Chang C-A. Nonisotopically labeled probes and primers. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR Protocols. San Diego: Academic Press; 1990. p. 99-111.
67. Ballagi-Pordány A, Ballagi-Pordány A, Funa K. Quantitative determination of mRNA phenotypes by the polymerase chain reaction. Anal Biochem 1991;196:89-94.
68. Greif M, Hockett R, Sobek H. Quantification of human cytokine mRNAs by competitive RT-PCR. In: Ziebolz B, editor. Biochemica. Mannheim, Germany: Roche Molecular Biochemicals; 1998. p. 36-7.
69. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
70. Celi FS, Zenilman ME, Shuldiner AR. A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res 1993;21:1047.
71. Heuvel JPV, Tyson FL, Bell DA. Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques 1993;14:395-8.
72. Prendergast JA, Helgason CD, Bleakley RC. Quantitative polymerase chain reaction analysis of cytotoxic cell proteinase gene transcripts in T cells. J Biol Chem 1992;267:5090-5.
73. Sommer SS, Sarkar G, Koeberl DD, Bottema CDK, Buerstedde J-M, Schowalter DB, et al. Direct sequencing with the aid of phage promoters. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR Protocols. San Diego: Academic Press; 1990. p. 197-205.
74. Gingeras TR, Davis GR, Whitefield KM, Chapelle HL, DiMichelle LJ, Kwoh DY. A transcription-based amplification system. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR Protocols. San Diego: Academic Press; 1990. p. 245-52.
75. Prediger E. Competitive RT-PCR made simple. Ambion Technotes 1998;5:1-2.
76. Dostal DE, Rothblum KN, Baker KM. An improved method for absolute quantification of mRNA using multiplex polymerase chain reaction: Determination of renin and angiotensinogen mRNA levels in various tissues. Anal Biochem 1994;223:239-50.
77. Santagati S, Bettini E, Asdente M, Muramatsu M, Maggi A. Theoretical considerations for the application of competitive polymerase chain reaction to the quantitation of a low abundance mRNA: Estrogen receptor. Biochem Pharmacol 1993; 46:1797-803.
78. Becker-Andre M, Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 1989;17:9437-46.
79. Ottander U, Leung CHB, Olofsson JI. Functional evidence for divergent receptor activation mechanisms of luteotropic and luteolytic events in the human corpus luteum. Mol Hum Reprod 1999;5:391-5.
80. Chaffin CL, Stouffer RL, Duffy DM. Gonadotropin and steroid regulation of steroid receptor and aryl hydrocarbon receptor messenger ribonucleic acid in Macaque granulosa cells during the periovulatory interval. Endocrinology 1999;140:4753-60.
81. Chelly J, Kaplan J-C, Maire P, Gautron S, Kahn A. Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 1988;333:858-60.
82. Willey JC, Crawford EL, Jackson CM, Weaver DA, Hoban JC, Khuder SA, et al. Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates. Am J Respir Cell Mol Biol 1998;19:6-17.
83. Stavréus-Evers A, Freyschuss B, Eriksson H. Hormonal regulation of the estrogen receptor in primary cultures of hepatocytes from female rats. Steroids 1997;62:647-54.
84. Diel P, Walter A, Fritzemeier KH, Hegele-Hartung C, Knauthe R. Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus. J Steroid Biochem Mol Biol 1995;55:363-73.
85. 9k gene expression during the perinatal period in the rat: Corrrelation to estrogen receptor expression in uterus. Mol Cell Endocrinol 1993;97:61-9.
86. Schummer B, Hauptfleisch S, Siegsmund M, Schummer M, Lemmer B. Highly accurate quantification of mRNA expression by means of titan one-tube RT-PCR and capillary electrophoresis. In: Ziebolz B, editor. Biochemica. Mannheim, Germany: Roche Molecular Biochemicals; 1998. p. 31-3.
87. Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci 1990;87:2725-9.
88. Siebert PD, Larrick JW. PCR MIMICS: Competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques 1993;14:244-9.
89. Diviacco S, Norio P, Zentilin L, Menzo S, Clementi M, Biamonyi G, et al. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene 1992;122:313-20.
90. Huang H-Y, Krüssel JS, Wen Y, Polan ML. Use of reverse transcription-polymerase chain reaction to detect embryonic interleukin-1 system messenger RNA in individual preimplantation mouse embryos co-cultured with Vero cells. Hum Reprod 1997;12:1537-44.
91. Kruessel JS, Huang H-Y, Wen Y, Kloodt AR, Bielfeld P, Polan ML. Different pattern of interleukin-1β-(IL-1 β), interleukin-1 receptor antagonist-(IL-1ra) and interleukin-1 receptor type I-(IL-1R tI) mRNA expression in single preimplantation mouse embryos at various developmental stages. J Reprod Immunol 1997;34:103-20.
92. Cook M, Lynch WH. A sensitive nested reverse transcriptase PCR assay to detect viable cells of the fish pathogen Renibacterium salmoninarum in Atlantic salmon (Salmo salar L.). Appl Environ Microbiol 1999;65:3042-7.
93. Raga F, Casan EM, Kruessel J, Wen Y, Bonilla-Musoles F, Polan ML. The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology 1999;140:3705-12.
94. Wohlfahrt S, Kleine B, Rossmanith WG. Detection of gonadotrophin releasing hormone and its receptor mRNA in human placental trophoblasts using in-situ reverse transcription-polymerase chain reaction. Mol Hum Reprod 1998;4:999-1006.
95. Rasmussen R, Morrison T, Herrmann, Wittwer C. Quantitative PCR by continuous fluorescence monitoring of a double strand DNA specific binding dye. In: Ziebolz B, editor. Biochemica. Mannheim, Germany: Roche Molecular Biochemicals; 1998. p. 8-11.
96. LightCycler System. Mannheim, Germany: Roche Diagnostics; 1998. http://www.biochem.roche.com/lightcycler.
97. Bièche I, Olivi M, Champème M-H, Vidaud D, Lidereau R, Vidaud M. Novel approach to quantitative polymerase chain reaction using real-time detection: Application to the detection. Int J Cancer 1998;78:661-6.
98. Nitsche A, Steuer N, Schmidt CA, Landt O, Siegert W. Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA. Clin Chem 1999;45:1932-7.
99. Raggi CC, Bagnoni ML, Tonini GP, Maggi M, Vona G, Pinzani P, et al. Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system. Clin Chem 1999;45:1918-24.
100. Bièche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, et al. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 1999;45:1148-56.
101. Laurendeau I, Buhuau M, Vodovar N, Larramendy C, Olivi M, Bieche I, et al. TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin Chem 1999;45: 982-6.
102. Klein D, Janda P, Steinborn R, Müller M, Salmons B, Günzburg WH. Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: Influence of mismatches on quantification. Electrophoresis 1999:20:291-9.
103. Loeffler J, Henke N, Hebart H, Schmidt D, Hagmeyer L, Schumacher U, et al. Quantification of fungal DNA by using fluorescence resonance energy transfer and the lightcycler system. J Clin Microbiol 2000;38:586-90.
104. DeSilva D, Reiser A, Herrmann M, Tabiti K, Wittwer C. Rapid genotyping and quantification on the LightCycler with hybridization probes. In: Ziebolz B, editor. BiochemiCa. Mannheim, Germany: Roche Molecular Biochemicals; 1998. p. 12-5.
105. Ligase Chain Reaction. Wiesbaden, Germany: Abbott Diagnostics, 1994.
106. Puolakkainen M, Hiltunen-Back E, Reunala T, Suhonen S, Lähteeenmäki P, Lehtinen M, et al. Comparison of performances of two commercially available tests, a PCR assay and ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol 1998;36: 1489-93.
107. Chernesky M, Chong S, Jang D, Luinstra K, Faught M, Mahony J. Inhibition of amplification of Chlamydia trachomatis plasmid DNA by the ligase chain reaction associated with female urines. Clin Microbiol Infect 1998;4:397-400.
108. Mahony J, Chong S, Jang D, Luinstra K, Faught M, Dalby D, et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: Identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998;36:3122-6.
109. Amplicor. Branchburg, NJ: Roche Diagnostics; 1997.
110. Chernesky MA, Chong S, Jang D, Luinstra K, Sellors J, Mahony JB. Ability of commercial ligase chain reaction and PCR assays to diagnose Chlamydia trachomatis infections in men by testing first-void urine. J Clin Microbiol 1997; 35:982-4.
111. Flouriot G, Pope C, Kenealy M-R, Gannon F. Improved efficiency for primer extension by using a long, highly-labeled primer generated from immobilized single-stranded DNA templates. Nucleic Acids Res 1997;25:1658-9.
112. McCaffrey TA, Du B, Fu C, Bray PJ, Sanborn TA, Deutsch E, et al. The expression of TGF-β receptors in human atherosclerosis: Evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Cardiol 1999;31: 1627-42.
113. Marshall KR, Field HJ. Demonstration of equine herpesvirus-1 neuronal latency in murine olfactory bulbs using a novel combined in situ PCR and protein synthesis method. Virology 1997;229:279-82.
114. Wiesner RJ. Direct quantification of picomolar concentrations of mRNAs by mathematical analysis of a reverse transcription/exponential polymerase chain reaction assay. Nucleic Acids Res 1992;20:5863-4.
115. Bouaboula M, Legoux P, Pességué B, Delpech B, Dumont X, Piechaczyk M, et al. Standardization of mRNA titration using a polymerase chain reaction method involving coamplification with a multispecific internal control. J Biol Chem 1992;267:21830-8.
116. DeMuth JP, Weaver DA, Crawford EL, Jackson CM, Willey JC. Loss of spr1 expression measurable by quantitative RT-PCR in human bronchogenic carcinoma cell lines. Am J Respir Cell Mol Biol 1998;19:25-9.
117. Willey JC, Coy EL, Frampton MW, Torres A, Apostolakos MJ, Hoehn G, et al. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am J Respir Cell Mol Biol 1997;17:114-24.
118. Lader E. Maximizing the accuracy of relative RT-PCR. Ambion TechNotes 1998;5:124.
119. Gaddum JH. Lognormal distributions. Nature 1945;156: 463-6.
120. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall; 1991.